Islet amyloid polypeptide (IAPP) secretion from pancreatic islets isolated from non-obese diabetic (NOD) mice

Regulatory Peptides

Volumn 63, Issue 1, 1996, Pages 39-45

  Karlsson, Ella ^a   Stridsberg, Mats ^a   Sandler, Stellan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Insulin; Islet amyloid polypeptide; NOD mice; Pancreatic islet; cell

Indexed keywords

AMYLIN; GLUCOSE; THEOPHYLLINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DNA CONTENT; FEMALE; HORMONE RELEASE; INSULIN RELEASE; INSULITIS; MALE; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0029887251     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-0115(96)00025-0     Document Type: Article

References (23)

1. Clark, A., Islet amyloid: an enigma of type 2 diabetes, Diabetes/Metab. Rev., 8 (1992) 117-132.
2. Cooper, G.J.S., Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease, Endocrine Rev., 15 (1994) 163-201.
3. Cooper, G.J.S., Leighton, B., Dimitriadis, G.D., Parry-Billings, M., Kowalchuk, J.M., Howland, K., Rothbard, J.B., Willis, A.C. and Reid, K.B.M., Amylin found in amyloid deposits in human type 2 diabetic patients, Proc. Natl. Acad. Sci. USA, 85 (1988) 7763-7766.
4. DeVroede, M., Foriers, A., Van de Winkel, M., Madsen, O. and Pipeleers, D., Presence of islet amyloid polypeptide in rat islet B and D cells determines parallelism and dissociation between rat pancreatic islet amyloid polypeptide and insulin content, Biochem. Biophys. Res. Commun., 182 (1992) 886-893.
5. Fehmann, H.C., Weber, V., Göke, R., Göke, B. and Arnold, R., Cosecretion of amylin and insulin from isolated rat pancreas, FEBS Lett., 262 (1990) 279-281.
6. Ganda, O.P., Srikanta, S., Brink, S.J., Morris, M.A., Gleason, R.E., Soeldner, J.S. and Eisenbarth, G.S., Differential sensitivity to B-cell secretagogues in 'early' type 1 diabetes mellitus, Diabetes, 33 (1984) 516-521.
7. Heding, L.G., Determination of total serum insulin (IRI) in insulin-treated patients, Diabetologia, 8 (1972) 260-266.
8. Hinegardner, R.T., An improved fluorometric assay for DNA, Anal. Biochem., 39 (1971) 197-201.
9. Kahn, S.E., D'Alessio, D.A., Schwartz, M.W., Fujimoto, W.Y., Ensick, J.W., Taborsky Jr. G.T. and Porte Jr., D., Evidence of secretion of islet amyloid polypeptide and insulin by β-cells, Diabetes, 39 (1990) 634-638.
10. Kanatsuka, A., Makino, H., Ohsawa, H., Tokuyama, Y., Yamaguchi, T., Yoshida, S. and Adachi, M., Secretion of islet amyloid polypeptide and insulin by β-cells, FEBS Lett., 259 (1989) 199-201.
11. Krebs, H.A. and Henseleit, K., Untersuchungen uber die Harnstoffbildung im Tierkörper, Hoppe-Seylers Z. Physiol. Chem., 210 (1932) 33-66.
12. Kolb, H., Mouse models of insulin-dependent diabetes: low dose streptozotocin-induced diabetes and nonobese diabetic (NOD) mice, Diabetes/Metab. Rev., 3 (1987) 751-778.
13. Leiter, E.H., Prochazka, M. and Coleman, D.L., Animal models of human disease: the nonobese diabetic (NOD) mouse, Am. J. Pathol., 128 (1987) 380-383.
14. Lorenzo, A., Razzaboni, B., Weir, G.C. and Yanker, B.A., Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus, Nature, 368 (1994) 756-760.
15. Mulder, H., Ahrén, B., Stridsberg, M. and Sundler, F., Non-parallelism of islet amyloid polypeptide (amylin) and insulin gene expression in rat islets following dexamethasone treatment, Diabetologia, 38 (1995) 395-402.
16. O'Brien, T.D., Westermark, P. and Johnson, K.H., Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated and dexamethasone-treated rats, Diabetes, 40 (1991) 1701-1706.
17. Strandell, E., Eizirik, D.L. and Sandler, S., Reversal of β-cell supression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus, J. Clin. Invest., 85 (1990) 1994-1950.
18. Stridsberg, M., Sandler, S. and Wilander, E., Cosecretion of islet amyloid polypeptide (IAPP) and insulin from isolated rat pancreatic islets following stimulation or inhibition of β-cell function, Regul. Pept., 45 (1993) 363-370.
19. Stridsberg, M., Wilander, E., Öberg, K., Lundqvist G. and Eriksson, B., Islet amyloid polypeptide (IAPP) producing pancreatic islet tumor. A clinical and biochemical characterization, Scand. J. Gastroenterol., 27 (1992) 381-387.
20. Tochino, Y., The NOD mouse as a model of type 1 diabetes, CRC Crit. Rev. Immunol., 8 (1987) 49-81.
21. Westermark, P., Johnson, K.H., O'Brien, T.D. and Betsholtz, C., Islet amyloid polypetide - a novel controversy in diabetes research, Diabetologia, 35 (1992) 297-303.
22. Westermark, P., Wernstedt, C., Wilander, E., Hayden, D.W., O'Brien, T.D. and Johnson, K.H., Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide like protein also present in normal islet cells, Proc. Natl. Acad. Sci. USA, 84 (1987) 3881-3885.
23. Westermark, P., Wernstedt, C., Wilander, E. and Sletten, K., A novel peptide in the calcitonin gene-related peptide family as an amyloid protein fibril in the endocrine pancreas, Biochem. Biophys. Res. Commun., 140 (1986) 827-831.